Every Cat Logo

Grants

EC24F-250: Investigating the effect of a ketogenic medium-chain triglyceride supplement on the treatment of cognitive dysfunction syndrome in cats.

As the number of elderly cats increases, effective management of their health is crucial. Cognitive Dysfunction Syndrome (CDS) is a common age-related condition in cats that affects their cognitive abilities and quality of life. While we know a lot about CDS in dogs, there is still much to learn about it in cats. This study aims to investigate the effects of a special dietary supplement on cats with CDS. The supplement contains medium-chain fatty acids(MCTs), which have been shown to have a positive impact on brain function in both dogs and humans. Forty-three client-owned cats will participate in the study. MCT oil will be added to their normal diet for 90 days and will be compared to the effects of olive oil as a control feed supplement for 90 days. We will be looking at how the supplement affects the cats’ behavior, cognitive abilities, and quality of life, including their microbiome and fecal metabolome. We will also be measuring a potential biomarker for CDS in the cats’ blood. This study has the potential to provide valuable insights into the effects of MCT dietary supplementation on CDS in cats, and may lead to the development of new treatment strategies for this common age-related disorder. By improving our understanding of CDS in cats, we can provide better care for these beloved pets and their owners.

Grant ID: EC25F-250

Status: Active

Year Funded: 2024

Amount awarded: $49,945

Investigator: Holger Andreas Volk; University of Veterinary Medicine Hannover